Logo-jcvtr

J Cardiovasc Thorac Res. 2019;11(3): 176-181. doi: 10.15171/jcvtr.2019.30
PMID: 31579456        PMCID: PMC6759619

Original Article

Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival

Brent Klinkhammer 1 * ORCID

Cited by CrossRef: 8

1- TAKAGI H, KUNO T, HARI Y, NAKASHIMA K, YOKOYAMA Y, UEYAMA H, ANDO T. Meta-analysis of impact of renin-angiotensin system inhibitors on survival after transcatheter aortic valve implantation. Minerva Cardiol Angiol. 2021;69(3) [Crossref]
2- Sun Y, Li J, Li G, Fan R, Luo J. Impact of renin–angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta‐analysis. Cathet Cardio Intervent. 2021;97(1) [Crossref]
3- Hosseinpour A, Gupta R. Outcomes of renin‐angiotensin inhibitors following transcatheter aortic valve implantation. Clinical Cardiology. 2024;47(2) [Crossref]
4- Guan Y, Kong X, Zhu H, Li H, Zhao L, Guo F, Lv Q. Association of renin–angiotensin system inhibitors use with short- and long-term mortality in patients with aortic stenosis: A systematic review and meta-analysis. Front Cardiovasc Med. 2023;9 [Crossref]
5- Bhat V, Kumar A, Kalra A. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers After Transcatheter Aortic Valve Replacement. JACC: Advances. 2024;3(5):100927 [Crossref]
6- Cao D, Giani J, Veiras L, Bernstein E, Okwan-Duodu D, Ahmed F, Bresee C, Tourtellotte W, Karumanchi S, Bernstein K, Khan Z. An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo. Sci Transl Med. 2021;13(604) [Crossref]
7- Bècle C, Riche B, Rabilloud M, Souteyrand G, Eltchaninoff H, Lefèvre T, Harbaoui B, Lantelme P. Role for Vascular Factors in Long-Term Outcomes After Transcatheter Aortic Valve Implantation. The American Journal of Cardiology. 2020;125(12):1884 [Crossref]
8- Guedeney P, Collet J. Rétrécissement aortique : mise au point. La Revue de Médecine Interne. 2022;43(3):145 [Crossref]
9- Hurrell H, Redwood M, Patterson T, Allen C. Aortic stenosis. BMJ. 2023;:e070511 [Crossref]
10- Wang S, Lin X, Guan Y, Huang J. The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9 [Crossref]